Exploring the mitochondrial microRNA import pathway through Polynucleotide Phosphorylase (PNPase). (September 2017)

• Record Type: Journal Article
• Authors: Shepherd, Danielle L.; Hathaway, Quincy A.; Pinti, Mark V.; Nichols, Cody E.; Durr, Andrya J.; Sreekumar, Shruthi; Hughes, Kristen M.; Stine, Seth M.; Martinez, Ivan; Hollander, John M.
• Is Part Of: Journal of molecular and cellular cardiology. Volume 110(2017)
• Page Start: 15
• Page End: 25
• Publication Date: 2017-09
• Subjects: Mitochondria -- microRNA -- Bioenergetics -- Diabetes mellitus; Cardiology -- Periodicals; Heart Diseases -- Periodicals; Molecular Biology -- Periodicals; Cardiologie -- Périodiques; Cardiology; Electronic journals; Periodicals; 616.12
• DOI: 10.1016/j.yjmcc.2017.06.012
• Languages: English
• ISSNs: 0022-2828

Abstract

Abstract: Cardiovascular disease is the primary cause of mortality for individuals with type 2 diabetes mellitus. During the diabetic condition, cardiovascular dysfunction can be partially attributed to molecular changes in the tissue, including alterations in microRNA (miRNA) interactions. MiRNAs have been reported in the mitochondrion and their presence may influence cellular bioenergetics, creating decrements in functional capacity. In this study, we examined the roles of Argonaute 2 (Ago2), a protein associated with cytosolic and mitochondrial miRNAs, and Polynucleotide Phosphorylase (PNPase), a protein found in the inner membrane space of the mitochondrion, to determine their role in mitochondrial miRNA import. In cardiac tissue from human and mouse models of type 2 diabetes mellitus, Ago2 protein levels were unchanged while PNPase protein expression levels were increased; also, there was an increase in the association between both proteins in the diabetic state. MiRNA-378 was found to be significantly increased in db/db mice, leading to decrements in ATP6 levels and ATP synthase activity, which was also exhibited when overexpressing PNPase in HL-1 cardiomyocytes and in HL-1 cells with stable miRNA-378 overexpression (HL-1-378). To assess potential therapeutic interventions, flow cytometry evaluated the capacity for targeting miRNA-378 species in mitochondria through antimiR treatment, revealing miRNA-378 level-dependent inhibition. Our study establishes PNPase as a contributor to mitochondrial miRNA import through the transport of miRNA-378, which may regulate bioenergetics during type 2 diabetes mellitus. Further, our data provide evidence that manipulation of PNPase levels may enhance the delivery of antimiR therapeutics to mitochondria in physiological and pathological conditions. Highlights: Polynucleotide Phosphorylase (PNPase) content is increased in diabetic mitocondria. Genetic manipulation of PNPase influences mitochondrial miR-378 content. Genetic manipulation of PNPase influences ATP6 and ATP synthase. PNPase interacts in a complex with RISC component Ago2 at the mitochondrion. PNPase overexpression facilitates mitochondrial antimiR delivery.